Sandu Pharmaceuticals Limited share price
BSE: SANDUPHQ
Key numbers
- Market cap
- ₹ 35.8 Cr
- Current price
- ₹ 37.00
- 52-week high / low
- ₹ 50 / 30
- Stock P/E
- 18.8
- Book value
- ₹ 40.3
- Dividend yield
- 2.70%
- ROCE
- 6.4%
- ROE
- 4.1%
- Debt to equity
- 0.01
- Sales growth (3 yrs)
- 2.3%
- Profit growth (3 yrs)
- 5.2%
- 1-year return
- -21.6%
About Sandu Pharmaceuticals Limited
Sandu Pharmaceuticals Limited manufactures and sells ayurvedic medicines under the SANDU brand in India and internationally. It offers immunity monsoon kit, sandu balm, sandu aptilift, sandu mahasudarshan kadha, sandu abhayarishta, sandu pathyadi kadha, sandu makarprash, sandu gulkand pravalyukta, sandu acivin herbal antacid, sandu ashwagandharishta, sandu amritarishta, sandu hemocleen excellent blood purifier, and sandu vanari granules. The company also provides mahasudarshan kadha, amritarishta, tab. samshamani vati, pathajeevani, vasa cough syrup, whoopin syrup, somajeevani, drakshasava, stressan, ashwagandharishtam, sandu sitopalasava, makarprash, chyavanprash, and ayush kwath. Its products are used for wellness, respiratory health, digestive health, and muscle and bone health. Sandu Pharmaceuticals Limited was founded in 1899 and is based in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 17 | 18 | 19 | 17 | 16 |
| Operating profit | 1 | 1 | 1 | 1 | 1 |
| Net profit | 0 | 1 | 1 | 0 | 0 |
| EPS (₹) | 0.23 | 0.54 | 1.01 | 0.04 | 0.37 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.